Combined analysis of cecal microbiota and metabolomics reveals the intervention mechanism of Dayuan Yin in acute lung injury

Lei Zhang, Wei Zhu, Zepeng ZhangFrontiers in Pharmacology 2024 · DOI

TL;DR

This study investigates how the traditional Chinese medicine formula, Dayuan Yin (DYY), treats acute lung injury (ALI) by analyzing its effects on the gut microbiome and metabolome in a rat model. DYY not only alleviates lung injury but also rebalances the gut's microbial composition and metabolic profiles, suggesting a crucial "gut-lung axis" mechanism in ALI treatment.

What Problem Does This Paper Address?

Acute lung injury (ALI) is a severe inflammatory condition with high mortality, and current treatments have limitations. While traditional Chinese medicine (TCM) has shown promise, its mechanisms are often complex and not fully understood. This paper addresses the need to elucidate the underlying mechanisms of TCM in treating ALI, specifically focusing on how Dayuan Yin (DYY), a long-standing formula for respiratory ailments, exerts its therapeutic effects. The study hypothesizes that DYY's efficacy is linked to its influence on the gut microbiome and its metabolic output, a concept supported by the growing understanding of the "gut-lung axis" – the bidirectional communication between the gut and the lungs.

Methods

The researchers employed a multi-omics approach to investigate DYY's effects.

  • ALI Model: Acute lung injury was induced in Sprague-Dawley rats using lipopolysaccharide (LPS).
  • DYY Intervention: Rats were treated with DYY, dexamethasone (a positive control), or saline.
  • Lung Injury Assessment: Lung injury was evaluated through histological analysis (H&E staining), measurement of lung wet-to-dry weight ratio, and quantification of inflammatory cytokines (IL-6, IL-1β, TNF-α) in bronchoalveolar lavage fluid (BALF).
  • 16S rRNA Gene Sequencing: Cecal contents were analyzed to characterize the gut microbial community structure and diversity.
  • Non-targeted Metabolomics: Cecal contents were subjected to UPLC-MS/MS analysis to identify and quantify metabolites.
  • Data Analysis:
    • Microbiota: Alpha and beta diversity analyses (PCoA, NMDS) were performed. Linear discriminant analysis effect size (LEfSe) was used to identify key microbial biomarkers. PICRUSt was employed to predict microbial functions.
  • Metabolomics: Multivariate statistical analyses (PCA, PLS-DA, OPLS-DA) were used to identify differential metabolites. Volcano plots and heatmaps visualized metabolite changes. Pathway analysis (MetaboAnalyst) identified affected metabolic pathways.
  • Correlation Analysis: Pearson's correlation analysis was used to examine the relationships between microbial taxa, differential metabolites, and inflammatory markers.
  • Network Analysis: Cytoscape was used to construct co-expression networks to visualize relationships between key genera and metabolites.

Datasets

  • Animal Model Data: Data was collected from Sprague-Dawley rats subjected to LPS-induced ALI and treated with DYY, dexamethasone, or saline.
  • Microbiota Data: 16S rRNA gene sequencing data from cecal contents of the experimental groups.
  • Metabolomics Data: UPLC-MS/MS data from cecal contents of the experimental groups.
  • Public Databases: HMDB and KEGG databases were used for metabolite and pathway annotation.
  • Repository Data: The metabolomics data is deposited in the Metabolights repository under accession number MTBLS10741.

Key Insights and Ideas

  • Gut-Lung Axis is Crucial for ALI: The study strongly supports the notion that ALI is not solely a lung-localized issue but is intricately linked to dysregulation in the gut microbiome and its metabolic products.
  • DYY as a Gut Modulator: DYY's therapeutic effect on ALI appears to be mediated, at least in part, by its ability to restore balance to the gut ecosystem, rather than just directly acting on the lungs.
  • Microbial Signatures of ALI: Specific bacterial phyla (e.g., increased Bacteroidota, decreased Firmicutes) and genera (e.g., increased Ruminococcus, Lactobacillus, Romboutsia) are identified as key players in LPS-induced ALI, and DYY can reverse these changes.
  • Metabolic Pathways as Therapeutic Targets: DYY's intervention in ALI involves modulating specific metabolic pathways, notably purine metabolism, which are disrupted by LPS.
  • Interconnectedness of Gut-Lung-Metabolism: The study highlights a complex interplay where gut microbial shifts lead to altered metabolite profiles, which in turn influence inflammatory responses in the lungs.

Key Results

  • Alleviation of Lung Injury: DYY significantly reduced lung injury markers, including lung wet/dry weight ratio, inflammatory cytokine levels (IL-6, IL-1β, TNF-α), and histological damage (Smith score), comparable to dexamethasone.
  • Microbial Community Restoration: DYY treatment partially restored the alpha diversity of the gut microbiota and shifted the beta diversity towards the control group, indicating a rebalancing effect.
  • Phylum and Genus Level Modulation: DYY reversed the LPS-induced changes in the abundance of key bacterial phyla (Bacteroidota, Firmicutes) and genera (Ruminococcus, Lactobacillus, Romboutsia).
  • Metabolite Normalization: DYY modulated the expression of 12 key metabolic biomarkers in ALI rats, returning them towards normal levels. This included restoring pathways like purine metabolism.
  • Correlation of Gut-Lung-Inflammation: Pearson's correlation analysis revealed significant links between specific gut bacteria, differential metabolites, and inflammatory markers, underscoring the integrated nature of ALI pathogenesis. For instance, TNF-α showed a negative correlation with certain metabolites, while IL-1β positively correlated with others.

Limitations and Future Work

  • Sample Size: The authors acknowledge that further research with a larger sample size is necessary to confirm their findings, particularly regarding the identification of specific bacteria as therapeutic markers.
  • Causality: While strong correlations were found, establishing definitive causal relationships between specific microbial shifts, metabolite changes, and ALI progression requires further investigation.
  • Pulmonary Microbiota: The study focused on the cecal microbiota. Future work should include sequencing of the lung microbiota to understand its role and interaction with the gut-lung axis in ALI.
  • Mechanism Elucidation: While DYY's effects on the gut-lung axis are demonstrated, a deeper understanding of the precise molecular mechanisms by which specific metabolites and bacteria influence lung inflammation is needed.
  • TCM Complexity: The study acknowledges the complexity of TCM and the need for further investigation into the intricate interactions between TCM components, the gut flora, and host physiology.

Summary updated

Abstract

The ancient Chinese medicinal formula, Dayuan Yin (DYY), has a long history of use in treating respiratory ailments and is shown to be effective in treating acute infectious diseases. This study aims to explore how DYY may impact intestinal flora and metabolites induced by acute lung injury (ALI). ALI rats were induced with lipopolysaccharide (LPS) to serve as models for assessing the anti-ALI efficacy of DYY through multiple lung injury indices. Changes in intestinal microflora were assessed via 16SrRNA gene sequencing, while cecum contents were analyzed using non-targeted metabonomics. Differential metabolites were identified through data analysis, and correlations between metabolites, microbiota, and inflammatory markers were examined using Pearson's correlation analysis. DYY demonstrated a significant improvement in LPS-induced lung injury and altered the composition of intestinal microorganisms, and especially reduced the potential harmful bacteria and enriched the beneficial bacteria. At the gate level, DYY exhibited a significant impact on the abundance of Bacteroidota and Firmicutes in ALI rats, as well as on the regulation of genera such as Ruminococcus, <i>Lactobacillus</i>, and Romboutsia. Additionally, cecal metabonomics analysis revealed that DYY effectively modulated the abnormal expression of 12 key metabolic biomarkers in ALI rats, thereby promoting intestinal homeostasis through pathways such as purine metabolism. Furthermore, Pearson's analysis indicated a strong correlation between the dysregulation of intestinal microbiota, differential metabolites, and inflammation. These findings preliminarily confirm that ALI is closely related to cecal microbial and metabolic disorders, and DYY can play a protective role by regulating this imbalance, which provides a new understanding of the multi-system linkage mechanism of DYY improving ALI.
BibTeX
@inproceedings{zhang2024combined,
  author = {Lei Zhang and Wei Zhu and Zepeng Zhang},
  title = {{Combined analysis of cecal microbiota and metabolomics reveals the intervention mechanism of Dayuan Yin in acute lung injury}},
  booktitle = {Frontiers in Pharmacology},
  year = {2024},
  doi = {10.3389/fphar.2024.1436017},
}
Figure